8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): October 28, 2004

Commission File No. 001-12392

NDCHealth Corporation

(Exact name of registrant as specified in its charter)

DELAWARE	58-0977458
(State or other jurisdiction of incorporation)	(IRS Employer Identification Number)

NDC Plaza, Atlanta, Georgia	30329-2010
(Address of principal executive offices)	(Zip Code)

Registrant’s telephone number, including area code (404) 728-2000

None

(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

ITEM 7.01 Regulation FD Disclosure.

On October 28, 2004, NDCHealth Corporation issued a press release announcing an internal review of the Company’s physician software exchange practices. The full text of the release is attached as exhibit 99.1.

The information in this Current Report on Form 8-K, including exhibit 99.1 attached hereto, is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall it be incorporated into future filings under the Securities Act of 1933, as amended, or under the Securities Exchange Act of 1934, as amended unless expressly set forth in such future filing that such information is to be considered “filed” or incorporated by reference therein.

ITEM 9.01 Financial Statements and Exhibits.

(c) Exhibits.

Exhibit Number	Exhibit Title
99.1	Press Release dated October 28, 2004.

1

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

NDCHealth Corporation
(Registrant)
By:	/s/ James W. FitzGibbons
	James W. FitzGibbons
	Vice President and Chief Accounting Officer

Date: October 28, 2004

2

EX-99.1

Exhibit 99.1

NDC Plaza

Atlanta, GA 30329-2010

404-728-2000

FOR IMMEDIATE RELEASE

NDCHealth to Review Physician Software Exchange Practices

ATLANTA, October 28, 2004 – NDCHealth Corporation (NYSE: NDC) today announced that, during the course of its ongoing operating procedures, the company has identified certain practices regarding the exchange of physician software inventory held by value added resellers that were inconsistent with company policies dealing with such exchanges.

A review of the physician business is ongoing, and the company has not determined the impact, if any, on its financial statements. This review, which will include the company’s independent auditors, is expected to be concluded prior to the release of the company’s fiscal second quarter results for the period ending November 26, 2004. The company intends to announce the results of this review as soon as it is in a position to do so.

NDCHealth’s physician business comprised approximately 8% of the company’s total revenue for the last 12 months.

About NDCHealth

NDCHealth is uniquely positioned in healthcare as a leading provider of point-of-care systems, electronic connectivity and information solutions to pharmacies, hospitals, physicians, pharmaceutical manufacturers and payers.

Cautionary Information Regarding Forward-Looking Statements

This press release contains forward-looking statements related to the company’s review or related to the company’s financial statements. These statements involve risks and uncertainties that may cause actual results to differ materially, and are only predictions and not guarantees of performance. More detailed risk factors and cautionary statements are included in NDCHealth’s Annual Report on Form 10-K for the fiscal year ended May 28, 2004 and other company filings with the Securities and Exchange Commission. Forward-looking statements speak only as of the date they are made, and the company undertakes no obligation to update publicly any of them in light of new information or future events.

###

Contact:

Robert Borchert

VP, Investor Relations

404-728-2906

robert.borchert@ndchealth.com